Clinical outcomes of early remdesivir administration in hospitalized patients at high risk for severe COVID-19 during the Omicron wave
Abstract Background Early remdesivir administration in high-risk patients with coronavirus disease 2019 (COVID-19) is known to be effective in preventing the progression to severe disease. However, the effect of early remdesivir administration on Omicron variants, which are known to have decreased s...
Saved in:
Main Authors: | Yeon Ju La, Won Sup Oh, Changhyup Kim, Myoung-nam Lim, Yong Duk Jeon |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-02-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12879-025-10585-3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Re-presentations to the emergency department initial presentation with COVID-19: Insights from the omicron wave
by: Daniella Audish, et al.
Published: (2025-03-01) -
Repetitive stability study of remdesivir/cyclodextrin complex on the international space station
by: György Dormán, et al.
Published: (2025-02-01) -
Does the COVID-19 XBB Omicron subvariant signal the beginning of the end of the pandemic?
by: Jinghao Nicholas Ngiam, et al.
Published: (2024-12-01) -
Reduced functional independence and multimorbidity increases the risk of severe infection among older patients with Omicron: a multicenter retrospective cohort study
by: Wan Yu, et al.
Published: (2025-02-01) -
Influence of sleep duration and quality on depression symptoms among nurses during the Omicron outbreak: a cross-sectional survey
by: Yingying Gu, et al.
Published: (2025-02-01)